Innovation in diabetic foot ulcer prevention – how we achieved ICS support and funding in 4 months

This session will demonstrate how an improvement idea became a NIHR adopted research trial which has gained ICS commitment and funding. The session will discuss how we chose to focus on primary prevention of foot ulcers in at risk patients with diabetes and how we convinced the ICS to support this idea. The session will also highlight the progress, challenges and opportunities during the implementation phase. We will also be discussing how we plan to use any positive research outcomes to demonstrate a return on investment and potential roll out of a foot ulcer prevention programme across the whole ICS.

Learning outcomes:

  • To understand how we gained support from emergent ICS leadership
  • To appreciate how we used modelling to make the business case and convince key stakeholders to support an emergent innovation. To share our key learning so that delegates can understand the challenges, barriers and opportunities in conducting clinical research
  • To share a rapid journey from an embryonic idea to the commencement of a full Randomised Controlled Trial in rapid time
  • To reflect on how the initiative could be adopted widely if proven successful

Tuesday 29 October 2019

10:10 - 10:50

Commissioning & Integrated Care

Speakers

Paul Mackenzie
Senior Network Manager, North West Diabetes Clinical Networks
Cheong Ooi
Consultant Physician - Diabetes & Endocrinology, Clinical Lead, Aintree University Hospital, Cheshire & Merseyside
Clinical Network Manager, NWCCN